Hamada Y. | Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
スポンサーリンク
概要
- HAMADA Yoshimasaの詳細を見る
- 同名の論文著者
- Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfiの論文著者
関連著者
-
Hamada Y.
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Horii Ikuo
Worldwide Safety Sciences
-
HORII Ikuo
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Yamada Hiroshi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
HAMADA Yoshimasa
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Yamada Hiroshi
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Yamada Hiroshi
worldwide safety sciences
-
Kurata Masaaki
ファイザー製薬中央研究所 安全性研究統括部
-
Yamasaki Naoko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
YAMASAKI Naoko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Kurata Masaaki
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Sasayama Yukiko
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Iidaka Takeshi
ファイザー 中央研究所
-
Iidaka Takeshi
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究統括部
-
Iidaka Takeshi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究
-
Shirai Maki
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Shirai Maki
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Tomizawa Kaori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
SASAYAMA Yukiko
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
MAKO Tomomi
Worldwide Safety Sciences, Global Research & Development Nagoya Laboratories, Pfizer Japan Inc.
-
KITAZAWA Ikue
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
Mako Tomomi
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
IIDAKA Takeshi
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
Iidaka Takeshi
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Fujikawa Masaaki
worldwide safety sciences
-
TOMIZAWA Kaori
Worldwide Safety Sciences
-
IDEGAMI Keiichi
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Idegami Keiichi
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Idegami Keiichi
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Kitazawa Ikue
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Fujikawa Masaaki
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Shiotani Motohiro
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Shiotani Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Shitoni Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Fujikawa Masaaki
World Wide Safety Sciences
-
IIDAKA TAKESHI
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Aoyama Hideyuki
Pharmacutical Sciences Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Zhou Yu
worldwide safety sciences
-
Sakimura Masanori
worldwide safety sciences
-
HORII Ikuo
Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
HAMADA Yoshimasa
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
SUGANO Kiyohiko
Worldwide Pharmaceutical Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer
-
KIKKAWA Rie
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Sato Yasushi
Worldwide Safety Sciences, PGRD Nagoya Laboratories, Pfizer Inc.
-
SHIOTANI Motohiro
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
KUNIHARA Mineo
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Sakimura Masanori
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Abe Junko
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Kikkawa Rie
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kunihara Mineo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
KURATA Masaaki
Toxicology Laboratory, Chugai Pharmaceutical Co., Ltd.
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Kurata Masaaki
Toxicology Laboratory Chugai Pharmaceutical Co.
-
Kikkawa Rie
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
SASAYAMA YUKIKO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
YAMASAKI NAOKO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
KITAZAWA IKUE
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
HAMADA YOSHIMASA
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
HORII IKUO
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
Mako Tomomi
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Sugano Kiyohiko
Worldwide Pharmaceutical Sciences Pfizer Global Research & Development Nagoya Laboratories Pfize
-
IIDAKA Tadashi
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Harada Takuma
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Harada Takuma
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
SHITONI Motohiro
Worldwide Safety Sciences, Global Research & Development Nagoya Laboratories, Pfizer Japan Inc.
-
Hamada Yoshimasa
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Horii Ikuo
Drug Safety Evaluation Pfizer Global Research And Development
-
TOMIZAWA KAORI
Pfizer WW Safety Sciences-Nagoya
-
YAMADA HIROSHI
Pfizer WW Safety Sciences-Nagoya
-
Horii Ikuo
Drug Safety Evaluation Global Research & Development Pfizer Inc.
-
Abe Junko
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Sato Yasushi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Hamada Yoshimasa
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
著作論文
- Development of in vitro 3T3 Cell Neutral Red Uptake Phototoxicity Screening System(Test methods, Proceedings of the 32nd Annual Meeting)
- PHYSICOCHEMICAL AND CELL-BASED APPROACH FOR EARLY SCREENING OF PHOSPHOLIPIDOSIS-INDUCING POTENTIAL
- Introduction of the in vivo Mini-tox study as an effective tool to improve confidence in safety in the early stage of drug development (2) Effects of atypical antipsychotics X(Test methods, Proceedings of the 32nd Annual Meeting)
- P8-34 Usefulness of beam walking test for prediction of adverse effects, "vertigo and dizziness"(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- SIMULTANEOUS MEASUREMENT OF NUCLEATED CELL COUNTS AND CELLULAR DIFFERENTIALS IN RAT BONE MARROW EXAMINATION USING FLOW CYTOMETER
- P7-45 Usefulness of fecal occult blood kits by the immunity method : Examination in rats and dogs(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- MECHANISM FOR SHORTENING PT AND APTT IN DOGS AND RATS : EFFECT OF FIBRINOGEN ON PT AND APTT
- Measurements for rat and canine D-dimer in plasma using human clinical latex agglutination reagents (BLOOD SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Mechanism for shortened PT and APTT in dogs and rats-Effect of fibrinogen on PT and APTT- (BLOOD SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- P7-58 Comparison of the chemicals on open-field activities in rats(ENDOCRINE AND NERVOUS SYSTEM)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Usefulness of Teflon sonde for oral administration in rats (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Battery of Tests for Profiling Abnormalities of Vitamin K-Dependent Coagulation Factors in Drug-Toxicity Studies in Rats
- P8-42 Technical examination for repeated blood collection and hematological tests in mice(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-20 Usefulness of measuring QT interval with chest lead in Beagle Dogs(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-33 Validation of an in vitro screening assay for phospholipidosis in drug development(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- The use of gene expression profiling in rat hepatocyte cultures using adapter-tagged competitive PCR (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)